CEACAM5 and neoplasm: Available clinical variables applied for analysis included clinicopathological factors such as sex (male vs. female), carcinoembryonic antigen (CEA, normal < 5 ng/ml vs. abnormal >  = 5 ng/ml), tumour grade (low vs. middle and high), and TNM stage (I-II vs. III-IV).